These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9421107)

  • 1. Cross-reactivity of TDX and OPUS immunoassay systems for serum digoxin determination.
    Okazaki M; Tanigawara Y; Kita T; Komada F; Okumura K
    Ther Drug Monit; 1997 Dec; 19(6):657-62. PubMed ID: 9421107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of digoxin concentrations determined by three assay systems: TDx, IMx and OPUS.
    Kagawa Y; Iwamoto T; Matsuda H; Mukohara R; Sawada J; Kojima M
    Biopharm Drug Dispos; 2004 Jan; 25(1):21-6. PubMed ID: 14716749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
    Dasgupta A; Johnson MJ
    J Clin Lab Anal; 2010; 24(6):413-7. PubMed ID: 21089173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance study of two digoxin assays in subjects with various degrees of renal function.
    Spinler SA; Al-Jazairi AS; Cheng JW; Kapoor S; Kobrin S; Shaw L
    Ther Drug Monit; 2000 Dec; 22(6):729-36. PubMed ID: 11128242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
    DeFrance A; Armbruster D; Petty D; Cooper KC; Dasgupta A
    Ther Drug Monit; 2011 Feb; 33(1):128-31. PubMed ID: 21079546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is free from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone.
    Datta P; Dasgupta A
    Ther Drug Monit; 2003 Aug; 25(4):478-82. PubMed ID: 12883233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
    Steimer W; Müller C; Eber B
    Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional (positive/negative) interference in a digoxin immunoassay: importance of antibody specificity.
    Datta P; Dasgupta A
    Ther Drug Monit; 1998 Jun; 20(3):352-7. PubMed ID: 9631936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
    Ferreri LF; Raisys VA; Opheim KE
    J Anal Toxicol; 1984; 8(3):138-40. PubMed ID: 6376949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
    Dasgupta A; Saffer H; Wells A; Datta P
    J Clin Lab Anal; 2002; 16(4):172-7. PubMed ID: 12112389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A; Tso G; Wells A
    Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ; Molitoris BA; Nakata LM; Gal J
    Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
    Dasgupta A; Johnson MJ; Sengupta TK
    J Clin Lab Anal; 2012 May; 26(3):143-7. PubMed ID: 22628228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.
    Dasgupta A; Kang E; Datta P
    J Clin Lab Anal; 2006; 20(5):204-8. PubMed ID: 16960898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of oleandrin and oleandrigenin in digitoxin immunoassays: minimal cross reactivity with a new monoclonal chemiluminescent assay and high cross reactivity with the fluorescence polarization assay.
    Datta P; Dasgupta A
    Ther Drug Monit; 1997 Aug; 19(4):465-9. PubMed ID: 9263390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytic performance of two automated nonpretreatment digoxin immunoassays.
    De BK; Booth DD; Magee PJ; Moore ML; Preuss TM; Rose TA; Roberts WL
    Ther Drug Monit; 1999 Feb; 21(1):123-8. PubMed ID: 10051065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein concentration on the determination of digoxin in serum by fluorescence polarization immunoassay.
    Porter WH; Haver VM; Bush BA
    Clin Chem; 1984 Nov; 30(11):1826-9. PubMed ID: 6207958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
    Chicella M; Branim B; Lee KR; Phelps SJ
    Ther Drug Monit; 1998 Jun; 20(3):347-51. PubMed ID: 9631935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable cross-reactivity of digoxin metabolites in digoxin immunoassays.
    Valdes R; Brown BA; Graves SW
    Am J Clin Pathol; 1984 Aug; 82(2):210-3. PubMed ID: 6380268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.